Government Initiatives and Expanding Access to Medication-Assisted Treatment (MAT) Drive Growth in Opioid Use Disorder (OUD) MarketAustin, United States, Feb. 06, 2025 (GLOBE NEWSWIRE) -- Opioid Use ...

For the first time in two decades, the Food and Drug Administration (FDA) has approved a new class of medication that provides an alternative to addictive opioids for patients looking to manage ...

Washington — Federal officials on Thursday approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.

WASHINGTON (AP) — Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and ...

WASHINGTON -- Federal officials on Thursday approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin.

The Food and Drug Administration (FDA) on Thursday approved Journavx (suzetrigine), a new non-opioid painkiller that promises to be nonaddictive. Journavx is approved to treat moderate-to-severe acute ...

The introduction of suzetrigine, a NaV1.8 inhibitor, is particularly promising because of its potential to address acute pain without relying on opioids. This medication’s novel mechanism and ...

By Jan Hoffman Seven months after the Supreme Court struck down a deal that would have resolved thousands of opioid cases against Purdue Pharma, the company’s owners, members of the Sackler ...

Tris Pharma has pointed to a phase 3 win for its pain relief drug as demonstrating the candidate’s potential to help resolve the opioid crisis. The company tested cebranopadol, a dual nociceptin ...